Overview
The purpose of this study is to evaluate the efficacy and safety of AD-218
Description
Condition or disease : Mixed Dyslipidemia Treatment Drug : AD-218, AD-218A, Placebo of AD-218, Placebo of AD-218A
Eligibility
Inclusion Criteria:
- A man or woman over 19 years old.
- Sign on ICF prior to study participation
Exclusion Criteria:
- History of Fibromyalgia, Myopathy etc (CK ≥ 2 X ULN)
- Other exclusions applied